AI주식인사이트AI Stock Insight
B

셀바이오휴먼텍

318160KOSDAQ기타 섬유제품 제조업

55.5 / 100

Reference Date: 2026-04-13

Financial Score25.0 / 40
News Sentiment12.5 / 25
Momentum8.0 / 20
Disclosure10.0 / 15
AI Analysis: ROE significantly exceeds the industry average but PBR raises overvaluation concerns. Slightly down 1.1% over the past month, with no recent news.

Company InformationBased on 2025 Annual Report

Business Overview

CellbiohumanTek, established in 2015, specializes in developing and manufacturing eco-friendly cellulose-based mask sheet materials. Its key products include biodegradable and vegan-certified materials like PT CELL and SEMI GEL, with expansion into medical fields such as hydrocolloid wound dressings. The company operates a non-woven fabric production plant in Vietnam to reduce reliance on imports and enhance cost efficiency and quality.

Number of Employees

97people

Average Salary

58.7M KRW

Score Calculation Basis

Detailed Financial Score

PER
6.70Industry Average 8.275.0Point

In line with industry avg

PBR
1.12Industry Average 0.390.0Point

2.9x industry avg (risky)

ROE
16.50Industry Average 3.257.0Point

5.1x industry avg (excellent)

Debt Ratio
17.38Industry Average 17.384.0Point

In line with industry avg

Trend 2023~20259.0 / 10 points
Revenue Growth Rate
3.0 / 3

Avg ▲41.9% (2-year basis)

Operating Profit Growth Rate
3.0 / 3

Avg ▲79.5% (2-year basis)

ROE Trend
3.0 / 4

Avg ROE 7.1% (improving, 3yr)

Detailed News Sentiment

0 totalPositive 0Neutral 0Negative 0

Detailed Momentum

52-week position3.0Point

52w lower range (32%)

Current 7,100Won52-week high 10,60052-week low 5,380
1-month return3.0Point

1m -1.11% (flat)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

12 totalPositive 0Neutral 12Negative 0
  • Neutral유형자산취득결정(자율공시)2026-04-09
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-04-07
  • Neutral정기주주총회결과2026-03-31
  • Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-03-30
  • Neutral[기재정정]사업보고서 (2025.12)2026-03-25